Tenaya Therapeutics Ownership | Who Owns Tenaya Therapeutics?
Tenaya Therapeutics Ownership Summary
Tenaya Therapeutics is owned by 27.86% institutional investors, 0.56% insiders, and 71.58% retail investors. Column group is the largest institutional shareholder, holding 5.75% of TNYA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.99% of its assets in Tenaya Therapeutics shares.
TNYA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Tenaya Therapeutics | 27.86% | 0.56% | 71.58% |
| Sector | Healthcare Stocks | 232.01% | 10.74% | -142.75% |
| Industry | Biotech Stocks | 381.47% | 10.55% | -292.02% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Column group | 9.40M | 5.75% | $6.69M |
| Vanguard group | 8.56M | 5.24% | $6.09M |
| Blackrock | 4.07M | 5.03% | $12.63M |
| Empery asset management, lp | 5.41M | 3.31% | $3.85B |
| Blackrock funding, inc. /de | 3.95M | 2.42% | $2.81M |
| Ghost tree capital | 1.35M | 1.67% | $4.18M |
| Renaissance | 1.85M | 1.13% | $1.32M |
| Gsa capital partners llp | 1.48M | 0.91% | $1.05M |
| Geode capital management | 1.19M | 0.73% | $849.41K |
| Euclidean capital | 1.02M | 0.62% | $1.65M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Column group | 9.40M | 8.08% | $6.69M |
| Empery asset management, lp | 5.41M | 3.40% | $3.85B |
| Ghost tree capital | 1.35M | 1.31% | $4.18M |
| Euclidean capital | 1.02M | 0.69% | $1.65M |
| Stepstone group lp | 462.16K | 0.35% | $748.70K |
| Diadema partners lp | 315.52K | 0.13% | $511.14K |
| Gsa capital partners llp | 1.48M | 0.09% | $1.05M |
| Persistent asset partners | 72.49K | 0.08% | $117.44K |
| Alphabet | 915.71K | 0.06% | $1.48M |
| Mirador capital partners lp | 582.52K | 0.06% | $414.47K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Empery asset management, lp | 5.41M | 3.40% | 5.41M |
| Vanguard group | 8.56M | 0.00% | 3.50M |
| Blackrock funding, inc. /de | 3.95M | - | 1.62M |
| Gsa capital partners llp | 1.48M | 0.09% | 1.02M |
| Ghost tree capital | 1.35M | 1.31% | 575.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -6.98M |
| Woodline partners lp | - | - | -5.92M |
| Octagon capital advisors lp | - | - | -2.58M |
| Integral health asset management | - | - | -2.38M |
| Vr adviser | - | - | -1.56M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Empery asset management, lp | 5.41M | 3.40% | 5.41M | $3.85B |
| Schonfeld strategic advisors | 465.96K | 0.00% | 465.96K | $754.85K |
| Diadema partners lp | 315.52K | 0.13% | 315.52K | $511.14K |
| Xtx topco | 97.84K | 0.01% | 97.84K | $158.50K |
| Persistent asset partners | 72.49K | 0.08% | 72.49K | $117.44K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -11.00 |
| Capital performance advisors llp | -12.00 |
| Srs capital advisors | -60.00 |
| Clearstead advisors | -82.00 |
| Rise advisors | -485.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 68 | -27.66% | 45,507,062 | 31.79% | 27 | 6.19% | 37 | 8.82% | 15 | -53.13% |
| Sep 30, 2025 | 91 | - | 34,496,870 | 9.27% | 21 | 5.63% | 34 | -24.44% | 31 | 29.17% |
| Jun 30, 2025 | 91 | -14.95% | 31,571,278 | -34.46% | 19 | 1.01% | 44 | -16.98% | 25 | -21.88% |
| Mar 31, 2025 | 2 | -97.70% | 32,748 | -99.92% | - | 0.00% | 1 | -97.92% | 1 | -94.74% |
| Dec 31, 2024 | 49 | -47.31% | 18,984,954 | -67.06% | 22 | 0.49% | 29 | -43.14% | 9 | -47.06% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 6.48M | 2.99% | - |
| US Small-Cap Growth II Equity Comp | 2.10M | 2.66% | -471.71K |
| T. Rowe Price New Horizons | 2.10M | 2.65% | -441.00 |
| Fidelity Select Biotechnology | 1.75M | 2.20% | - |
| JPMorgan US Small Company L | 785.69K | 0.91% | -315.70K |
| T. Rowe Price New Horizons Tr-Z | 554.73K | 0.70% | 9.11K |
| iShares Biotechnology ETF | 1.45M | 0.67% | 1.45M |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.11M | 0.51% | - |
| Raiffeisen-Health&Wellbeing-ESG Akt A | 900.00K | 0.42% | 150.00K |
| Fidelity Small Cap Index | 608.02K | 0.37% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 25, 2026 | COLUMN GROUP III GP, LP | - | Sell | $1.05M |
| Feb 24, 2026 | COLUMN GROUP III GP, LP | - | Sell | $190.27K |
| Feb 24, 2026 | COLUMN GROUP III GP, LP | - | Sell | $214.87K |
| Feb 20, 2026 | COLUMN GROUP III GP, LP | - | Sell | $170.80K |
| Feb 23, 2026 | COLUMN GROUP III GP, LP | - | Sell | $96.92K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 20 |
| 2025 Q4 | - | 3 |
| 2025 Q3 | - | 9 |
| 2025 Q2 | - | 3 |
| 2025 Q1 | 6 | 8 |
TNYA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools